FDA Moves to Withdraw Approval for Liquid Simvastatin Suspension
The FDA has initiated proceedings to remove FloLipid, a liquid form of the statin simvastatin, from the market after the manufacturer repeatedly failed to submit mandatory annual reports.
🧠Mind & Mental HealthPhoto: medpagetoday.com
Key points
- The FDA is seeking to withdraw approval for FloLipid, a liquid simvastatin suspension.
- The action stems from the manufacturer's repeated failure to submit mandatory annual reports.
- Patients and doctors can explore alternative liquid options, such as atorvastatin oral suspension.
Federal regulators have announced plans to withdraw approval for simvastatin oral suspension, marketed under the brand name FloLipid, due to regulatory non-compliance by manufacturer Salerno Pharma. According to a notice published in the Federal Register by top FDA drug regulator Michael Davis, MD, PhD, the company has consistently neglected to file required annual reports that detail necessary labeling updates, chemistry data, and manufacturing specifications. The agency is providing the drugmaker an opportunity to request a formal hearing before finalizing the withdrawal.
Initially cleared by regulators in 2016, the oral suspension was designed specifically to help patients who struggle with swallowing traditional pills manage their LDL cholesterol levels. While the medication provided a liquid alternative, statin therapies carry recognized safety considerations, including potential risks of myopathy and rhabdomyolysis at higher doses, alongside rare reports of immune-mediated necrotizing myopathy added to the product label in 2020. Patients currently utilizing liquid statin formulations who have concerns regarding their treatment plan should consult a healthcare provider to discuss alternative options, such as other available liquid cholesterol medications like atorvastatin oral suspension.
Source medpagetoday.com — medpagetoday.com/cardiology/dyslipidemia/123922 ↗
Read next
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🏥Public HealthRecall Issued for Generic Propranolol Over Potential Metal Contamination
Breckenridge Pharmaceutical has initiated a voluntary recall of one lot of generic propranolol capsules due to the potential presence of metal fragments.
🥗NutritionUnderstanding Food Science: Why Some Leftovers Freeze Better Than Others
Freezing leftovers is an effective way to minimize food waste, though the success of the process depends on the cellular structure and composition of the food being store…